Published in Virology on April 11, 2013
Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome. Cell Host Microbe (2013) 1.97
An Intrinsically Disordered Peptide from Ebola Virus VP35 Controls Viral RNA Synthesis by Modulating Nucleoprotein-RNA Interactions. Cell Rep (2015) 1.07
Assembly of the Ebola Virus Nucleoprotein from a Chaperoned VP35 Complex. Cell Rep (2015) 0.99
Analysis of the highly diverse gene borders in Ebola virus reveals a distinct mechanism of transcriptional regulation. J Virol (2014) 0.83
HSP90 Chaperoning in Addition to Phosphoprotein Required for Folding but Not for Supporting Enzymatic Activities of Measles and Nipah Virus L Polymerases. J Virol (2016) 0.78
Dynamic Phosphorylation of VP30 Is Essential for Ebola Virus Life Cycle. J Virol (2016) 0.76
The host E3-Ubiquitin ligase TRIM6 ubiquitinates the Ebola virus VP35 protein and promotes virus replication. J Virol (2017) 0.75
Antibodies to the core proteins of Nairobi sheep disease virus/Ganjam virus reveal details of the distribution of the proteins in infected cells and tissues. PLoS One (2015) 0.75
The impact of "omic" and imaging technologies on assessing the host immune response to biodefence agents. J Immunol Res (2014) 0.75
Ebola Virus Does Not Induce Stress Granule Formation during Infection and Sequesters Stress Granule Proteins within Viral Inclusions. J Virol (2016) 0.75
Molecular Function Analysis of Rabies Virus RNA Polymerase L Protein by Using an L Gene-Deficient Virus. J Virol (2017) 0.75
Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems. J Virol (1999) 4.32
Sequence comparison of five polymerases (L proteins) of unsegmented negative-strand RNA viruses: theoretical assignment of functional domains. J Gen Virol (1990) 3.72
Complexes of Sendai virus NP-P and P-L proteins are required for defective interfering particle genome replication in vitro. J Virol (1992) 2.73
Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture. J Virol (2002) 2.58
The Ebola virus VP35 protein is a suppressor of RNA silencing. PLoS Pathog (2007) 2.48
Interactions of Marburg virus nucleocapsid proteins. Virology (1998) 2.37
Production of novel ebola virus-like particles from cDNAs: an alternative to ebola virus generation by reverse genetics. J Virol (2004) 2.09
The VP35 protein of Ebola virus inhibits the antiviral effect mediated by double-stranded RNA-dependent protein kinase PKR. J Virol (2006) 2.00
An N-terminal domain of the Sendai paramyxovirus P protein acts as a chaperone for the NP protein during the nascent chain assembly step of genome replication. J Virol (1995) 1.98
Characterization of the L gene and 5' trailer region of Ebola virus. J Gen Virol (1999) 1.63
Homo-oligomerization facilitates the interferon-antagonist activity of the ebolavirus VP35 protein. Virology (2005) 1.63
Sendai virus RNA-dependent RNA polymerase L protein catalyzes cap methylation of virus-specific mRNA. J Biol Chem (2004) 1.54
Phosphorylation of VP30 impairs ebola virus transcription. J Biol Chem (2002) 1.47
Ebola virus VP35 antagonizes PKR activity through its C-terminal interferon inhibitory domain. J Virol (2009) 1.46
Deletion analysis defines a carboxyl-proximal region of Sendai virus P protein that binds to the polymerase L protein. Virology (1994) 1.44
A reconstituted replication and transcription system for Ebola virus Reston and comparison with Ebola virus Zaire. Virology (2005) 1.40
Molecular architecture of the vesicular stomatitis virus RNA polymerase. Proc Natl Acad Sci U S A (2010) 1.35
Mapping the interacting domains between the rabies virus polymerase and phosphoprotein. J Virol (1998) 1.34
Mutations within the 5' nontranslated RNA of cell culture-adapted hepatitis A virus which enhance cap-independent translation in cultured African green monkey kidney cells. J Virol (1996) 1.34
Mutations in conserved domain I of the Sendai virus L polymerase protein uncouple transcription and replication. Virology (1995) 1.33
The nucleotide sequence of the L gene of Marburg virus, a filovirus: homologies with paramyxoviruses and rhabdoviruses. Virology (1992) 1.32
Homo-oligomerization of Marburgvirus VP35 is essential for its function in replication and transcription. J Virol (2005) 1.30
Role of Ebola virus VP30 in transcription reinitiation. J Virol (2008) 1.28
Ebolavirus proteins suppress the effects of small interfering RNA by direct interaction with the mammalian RNA interference pathway. J Virol (2011) 1.28
RNA polymerase I-driven minigenome system for Ebola viruses. J Virol (2005) 1.27
Ribose 2'-O methylation of the vesicular stomatitis virus mRNA cap precedes and facilitates subsequent guanine-N-7 methylation by the large polymerase protein. J Virol (2009) 1.27
Mapping of a region of the paramyxovirus L protein required for the formation of a stable complex with the viral phosphoprotein P. J Virol (1994) 1.21
Stabilization of vesicular stomatitis virus L polymerase protein by P protein binding: a small deletion in the C-terminal domain of L abrogates binding. Virology (1996) 1.16
Rescue of recombinant Marburg virus from cDNA is dependent on nucleocapsid protein VP30. J Virol (2006) 1.15
The Ebola virus ribonucleoprotein complex: a novel VP30-L interaction identified. Virus Res (2008) 1.13
Mechanism of RNA synthesis initiation by the vesicular stomatitis virus polymerase. EMBO J (2012) 1.12
Filoviral immune evasion mechanisms. Viruses (2011) 1.10
Intragenic complementation and oligomerization of the L subunit of the sendai virus RNA polymerase. Virology (2002) 1.10
Filovirus replication and transcription. Future Virol (2007) 1.09
Basic residues within the ebolavirus VP35 protein are required for its viral polymerase cofactor function. J Virol (2010) 1.07
The phosphoprotein (P) and L binding sites reside in the N-terminus of the L subunit of the measles virus RNA polymerase. Virology (2004) 1.07
The respiratory syncytial virus polymerase has multiple RNA synthesis activities at the promoter. PLoS Pathog (2012) 1.07
The L polymerase protein of parainfluenza virus 3 forms an oligomer and can interact with the heterologous Sendai virus L, P and C proteins. Virology (2004) 1.04
An amino-proximal domain of the L protein binds to the P protein in the measles virus RNA polymerase complex. Virology (1994) 1.02
Role of VP30 phosphorylation in the Ebola virus replication cycle. J Infect Dis (2011) 1.00
The HR motif in the RNA-dependent RNA polymerase L protein of Chandipura virus is required for unconventional mRNA-capping activity. J Gen Virol (2010) 0.90
The importance of the NP: VP35 ratio in Ebola virus nucleocapsid formation. J Infect Dis (2011) 0.90
The L-L oligomerization domain resides at the very N-terminus of the sendai virus L RNA polymerase protein. Virology (2003) 0.89
Rinderpest virus RNA polymerase subunits: mapping of mutual interacting domains on the large protein L and phosphoprotein p. Virus Genes (2004) 0.87
Human parainfluenza virus type 2 L protein regions required for interaction with other viral proteins and mRNA capping. J Virol (2010) 0.86
The phosphoprotein (P) binding site resides in the N terminus of the L polymerase subunit of sendai virus. J Virol (2002) 0.86
Phosphoprotein, P of human parainfluenza virus type 3 prevents self-association of RNA-dependent RNA polymerase, L. Virology (2008) 0.85
Two regions of the P protein are required to be active with the L protein for human parainfluenza virus type 1 RNA polymerase activity. Virology (2001) 0.85
Characterization of the RNA silencing suppression activity of the Ebola virus VP35 protein in plants and mammalian cells. J Virol (2012) 0.84
Recombinant Marburg virus expressing EGFP allows rapid screening of virus growth and real-time visualization of virus spread. J Infect Dis (2011) 0.83
Purification and functional characterization of the full length recombinant Ebola virus VP35 protein expressed in E. coli. Protein Expr Purif (2009) 0.77
Incomplete polypeptides of in vitro translation for epitope localization. Methods Mol Biol (1996) 0.76
The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J Virol (2003) 4.73
Processing of genome 5' termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS One (2008) 2.45
Two key residues in ephrinB3 are critical for its use as an alternative receptor for Nipah virus. PLoS Pathog (2006) 2.26
Global suppression of the host antiviral response by Ebola- and Marburgviruses: increased antagonism of the type I interferon response is associated with enhanced virulence. J Virol (2006) 2.14
Rapid detection protocol for filoviruses. J Clin Virol (2004) 2.13
Ebola virus VP30-mediated transcription is regulated by RNA secondary structure formation. J Virol (2002) 1.71
Marburg virus evades interferon responses by a mechanism distinct from ebola virus. PLoS Pathog (2010) 1.63
VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice. Antimicrob Agents Chemother (2006) 1.63
Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae. Arch Virol (2012) 1.59
Phosphorylation of VP30 impairs ebola virus transcription. J Biol Chem (2002) 1.47
Ebola virus VP35 antagonizes PKR activity through its C-terminal interferon inhibitory domain. J Virol (2009) 1.46
A reconstituted replication and transcription system for Ebola virus Reston and comparison with Ebola virus Zaire. Virology (2005) 1.40
Forty-five years of Marburg virus research. Viruses (2012) 1.34
Ebola virus transcription activator VP30 is a zinc-binding protein. J Virol (2003) 1.29
Discussions and decisions of the 2012–2014 International Committee on Taxonomy of Viruses (ICTV) Filoviridae Study Group, January 2012–June 2013. Arch Virol (2014) 1.27
Oligomerization of Ebola virus VP30 is essential for viral transcription and can be inhibited by a synthetic peptide. J Biol Chem (2003) 1.24
Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae. Arch Virol (2013) 1.16
Rescue of recombinant Marburg virus from cDNA is dependent on nucleocapsid protein VP30. J Virol (2006) 1.15
The Ebola virus genomic replication promoter is bipartite and follows the rule of six. J Virol (2005) 1.14
Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA. Arch Virol (2013) 1.10
Development of a broad-spectrum antiviral with activity against Ebola virus. Antiviral Res (2009) 1.06
Severe acute respiratory syndrome coronavirus triggers apoptosis via protein kinase R but is resistant to its antiviral activity. J Virol (2008) 1.06
Structural and functional characterization of Reston Ebola virus VP35 interferon inhibitory domain. J Mol Biol (2010) 1.04
Role of N-linked glycans on bunyamwera virus glycoproteins in intracellular trafficking, protein folding, and virus infectivity. J Virol (2005) 1.02
Antiviral activity of a small-molecule inhibitor of filovirus infection. Antimicrob Agents Chemother (2010) 1.02
Intracellular events and cell fate in filovirus infection. Viruses (2011) 1.01
The antiviral effect of interferon-beta against SARS-coronavirus is not mediated by MxA protein. J Clin Virol (2004) 1.01
Identification of essential filovirion-associated host factors by serial proteomic analysis and RNAi screen. Mol Cell Proteomics (2010) 0.98
Functional analysis of the Bunyamwera orthobunyavirus Gc glycoprotein. J Gen Virol (2009) 0.97
The marburg virus 3' noncoding region structurally and functionally differs from that of ebola virus. J Virol (2009) 0.96
The Marburg virus surface protein GP is phosphorylated at its ectodomain. Virology (2002) 0.89
Establishment and characterization of plasmid-driven minigenome rescue systems for Nipah virus: RNA polymerase I- and T7-catalyzed generation of functional paramyxoviral RNA. Virology (2007) 0.86
Recombinant Marburg virus expressing EGFP allows rapid screening of virus growth and real-time visualization of virus spread. J Infect Dis (2011) 0.83
Ebola virus does not block apoptotic signaling pathways. J Virol (2013) 0.82
Ebola virus VP35 induces high-level production of recombinant TPL-2-ABIN-2-NF-κB1 p105 complex in co-transfected HEK-293 cells. Biochem J (2013) 0.79
Purification and functional characterization of the full length recombinant Ebola virus VP35 protein expressed in E. coli. Protein Expr Purif (2009) 0.77
Nitrogen dioxide induces apoptosis and proliferation but not emphysema in rat lungs. Thorax (2007) 0.75